ReviewFrontiers in pharmacology2022

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment.

Lili Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.